AMRCX
Price
$5.22
Change
-$0.08 (-1.51%)
Updated
Feb 21 closing price
Net Assets
19.34M
GFACX
Price
$65.66
Change
-$1.58 (-2.35%)
Updated
Feb 21 closing price
Net Assets
304.33B
Ad is loading...

AMRCX vs GFACX

Header iconAMRCX vs GFACX Comparison
Open Charts AMRCX vs GFACXBanner chart's image
American Growth One C
Price$5.22
Change-$0.08 (-1.51%)
VolumeN/A
Net Assets19.34M
American Funds Growth Fund of Amer C
Price$65.66
Change-$1.58 (-2.35%)
VolumeN/A
Net Assets304.33B
AMRCX vs GFACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AMRCX vs. GFACX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRCX is a StrongBuy and GFACX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 304B vs. AMRCX (19.3M). AMRCX (0.00) and GFACX (0.00) have matching dividends . AMRCX was incepted earlier than GFACX: AMRCX (29 years) vs GFACX (24 years). GFACX is a more actively managed with annual turnover of: 31.00 vs. AMRCX (3.00). AMRCX has a lower initial minimum investment than GFACX: AMRCX (0) vs GFACX (250). GFACX annual gain was more profitable for investors over the last year : 10.15 vs. AMRCX (-3.15). GFACX return over 5 years is better than : 32.83 vs. AMRCX (-5.95).
AMRCXGFACXAMRCX / GFACX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence29 years24 years-
Gain YTD-2.2472.980-75%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets19.3M304B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year-3.1510.15-31%
Returns for 3 years-4.0417.69-23%
Returns for 5 years-5.9532.83-18%
Returns for 10 years37.7355.6368%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HLN10.080.18
+1.82%
Haleon plc
SANM85.72-2.84
-3.21%
Sanmina Corp
HMST9.80-0.33
-3.26%
HomeStreet
ATNM1.17-0.06
-4.88%
Actinium Pharmaceuticals
EVEX4.17-0.33
-7.33%
Eve Holding